ATE324446T1 - Mutante formen von etxb und ctxb und ihre verwendung als träger - Google Patents
Mutante formen von etxb und ctxb und ihre verwendung als trägerInfo
- Publication number
- ATE324446T1 ATE324446T1 AT02740892T AT02740892T ATE324446T1 AT E324446 T1 ATE324446 T1 AT E324446T1 AT 02740892 T AT02740892 T AT 02740892T AT 02740892 T AT02740892 T AT 02740892T AT E324446 T1 ATE324446 T1 AT E324446T1
- Authority
- AT
- Austria
- Prior art keywords
- etxb
- ctxb
- carriers
- mutant
- mutant forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0115382.4A GB0115382D0 (en) | 2001-06-22 | 2001-06-22 | Mutant |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE324446T1 true ATE324446T1 (de) | 2006-05-15 |
Family
ID=9917219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02740892T ATE324446T1 (de) | 2001-06-22 | 2002-06-20 | Mutante formen von etxb und ctxb und ihre verwendung als träger |
Country Status (7)
Country | Link |
---|---|
US (2) | US7422752B2 (de) |
EP (1) | EP1402039B1 (de) |
AT (1) | ATE324446T1 (de) |
DE (1) | DE60210970T2 (de) |
ES (1) | ES2260445T3 (de) |
GB (1) | GB0115382D0 (de) |
WO (1) | WO2003000899A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006041983A2 (en) * | 2004-10-06 | 2006-04-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Acting For The Louisiana State University Health Sciences Center In New Orleans | Channel current cheminformatics and bioengineering methods for immunological screening, single-molecule analysis, and single-molecular-interaction analysis |
US9120111B2 (en) | 2012-02-24 | 2015-09-01 | Rain Bird Corporation | Arc adjustable rotary sprinkler having full-circle operation and automatic matched precipitation |
US9156043B2 (en) | 2012-07-13 | 2015-10-13 | Rain Bird Corporation | Arc adjustable rotary sprinkler with automatic matched precipitation |
MX2015012461A (es) | 2013-03-15 | 2016-08-08 | Bioven 3 Ltd | Proteinas sintéticas autoensamblables. |
WO2018111018A2 (ko) * | 2016-12-16 | 2018-06-21 | 한양대학교 에리카산학협력단 | 플라스미드 기반의 ctx 파지 복제시스템 및 ctx 파지에 감염되고 콜레라 독소를 생산할 수 있는 비브리오 콜레라 균주 |
US11136358B2 (en) | 2016-12-16 | 2021-10-05 | Industry-University Cooperation Foundation Hanyang University Erica Campus | Plasmid-based CTX phage replication system and vibrio cholerae strain that can be infected by CTX phage and can be used for cholera toxin production |
CN113388008B (zh) * | 2021-06-25 | 2023-04-28 | 太原师范学院 | 一种细胞内质网靶向的自释放型蛋白运输载体lca2及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9513733D0 (en) * | 1995-07-05 | 1995-09-06 | Univ Bristol | Therapeutic agents |
EP1075274A2 (de) * | 1998-05-08 | 2001-02-14 | University Of Bristol | Immunomodulatoren für impstoffen |
GB9819484D0 (en) * | 1998-09-07 | 1998-10-28 | Univ Bristol | Therapeutic agents |
WO2001027144A2 (en) * | 1999-10-08 | 2001-04-19 | Active Biotech Ab | Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
-
2001
- 2001-06-22 GB GBGB0115382.4A patent/GB0115382D0/en not_active Ceased
-
2002
- 2002-06-20 AT AT02740892T patent/ATE324446T1/de not_active IP Right Cessation
- 2002-06-20 EP EP02740892A patent/EP1402039B1/de not_active Expired - Lifetime
- 2002-06-20 DE DE60210970T patent/DE60210970T2/de not_active Expired - Lifetime
- 2002-06-20 WO PCT/GB2002/002829 patent/WO2003000899A1/en not_active Application Discontinuation
- 2002-06-20 ES ES02740892T patent/ES2260445T3/es not_active Expired - Lifetime
-
2003
- 2003-12-22 US US10/743,391 patent/US7422752B2/en not_active Expired - Fee Related
-
2008
- 2008-04-30 US US12/112,952 patent/US8425917B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1402039B1 (de) | 2006-04-26 |
GB0115382D0 (en) | 2001-08-15 |
US7422752B2 (en) | 2008-09-09 |
ES2260445T3 (es) | 2006-11-01 |
WO2003000899A1 (en) | 2003-01-03 |
US20080305125A1 (en) | 2008-12-11 |
DE60210970D1 (de) | 2006-06-01 |
US20060002905A1 (en) | 2006-01-05 |
DE60210970T2 (de) | 2007-01-04 |
EP1402039A1 (de) | 2004-03-31 |
US8425917B2 (en) | 2013-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE490311T1 (de) | Mutanten der alpha-amylase | |
TR200200068T2 (tr) | Nematisital triflüorobütenler | |
ID23374A (id) | Halogenopirimidin | |
YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
DE10294792D2 (de) | Beschichtung von Stents zur Verhinderung von Restenose | |
DE60137307D1 (de) | Substituierte sapogenine und ihre verwendung | |
DE69904249D1 (de) | 2,2-Dimethylcyclopropansäureester und ihre Verwendung als Pestizide | |
DE50208918D1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
DE60313895D1 (de) | 2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren | |
ATE324446T1 (de) | Mutante formen von etxb und ctxb und ihre verwendung als träger | |
MY136297A (en) | Piperazine derivatives having sst1 antagonistic activity | |
ATE253059T1 (de) | Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer | |
DK1204659T3 (da) | Serotonerge benzofuraner | |
BRPI0408117A (pt) | compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos | |
SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
DE50313185D1 (de) | 2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva | |
DE60319989D1 (de) | Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande | |
MXPA04000623A (es) | Derivados de tetrahidropiridazina y su uso como pesticidas. | |
DK1051404T3 (da) | Substituerede phenyluraciler med herbicid virkning | |
DE59808166D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum | |
BR9808210A (pt) | Befeniloxazolinas dissubstituìdas | |
ATE389014T1 (de) | Phosphorylierte glyoxalase i und deren verwendung | |
MXPA04004262A (es) | Delta-1-pirrolinas. | |
ATE465248T1 (de) | Humane cyclooxygenase-3 und ihre verwendung | |
ATA106398A (de) | Verwendung von caroverin und/oder caroverin. hydrochlorid zur herstellung von als antioxidantien wirkenden zusammensetzungen und/oder von neuroregenerativen zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |